Incannex authorizes $20M share repurchase program

Incannex (IXHL) Healthcare announced that its Board of Directors has authorized a share repurchase program for up to $20M of the Company’s outstanding shares of common stock. The timing and amount of any repurchases will depend on market conditions, available capital resources, and other factors. Incannex Healthcare President and CEO Joel Latham commented, “The approval of this $20 million repurchase program reflects our confidence in the strength of our pipeline, the resilience of our strategy, and the opportunities ahead. We believe the current market valuation does not accurately reflect the significant progress we have made across our clinical programs. This initiative allows us to act decisively, strengthen our capital management strategy, and potentially enhance long-term value creation for shareholders.”